pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·35m ago·1 min read
save

Sanofi considering a deal to acquire Insmed, according to report

Nov 19, 2026·read at Endpoints ↗

Sanofi is looking at a deal to buy the US drugmaker Insmed, Bloomberg News reported Thursday, in what would be one of the biggest biopharma takeovers of the last several years. The Bloomberg report made ...

source

Reporting by Endpoints.

read at Endpoints ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 30m agoChinese AI lab MegaRobo raises nearly $200M; Isomorphic partners with MerckEndpoints
  • 48m agoWhy Oura is buying CounselEndpoints
  • 1h agoNovartis details eczema win, autoimmune CAR-T efforts after rocky quarterEndpoints
  • 2h agoRegeneron enters neurology field as FDA approves siRNA for myasthenia gravisEndpoints
  • 3h agoLilly adds General Medicine for Alzheimer's disease diagnosisEndpoints